相似文献/References:
[1]周文兰,吴湖炳,韩彦江,等.18F-FDG PET/CT对骨骼孤立性高代谢病灶的初步诊断价值[J].国际放射医学核医学杂志,2015,39(1):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]
Zhou Wenlan,Wu Hubing,Han Yanjiang,et al.Preliminary study of 18F-FDG PET/CT in the diagnosis of solitary hypermetabolic lesion of bone[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]
[2]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[3]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
[4]栾兆生,周雯,唐为国,等.99Tcm标记化合物显像检测冠心病的优化方案探讨[J].国际放射医学核医学杂志,2010,34(1):42.[doi:10.3760/cma.j.issn.1673-4114.2010.01.011]
LUAN Zhao-sheng,ZHOU Wen,TANG Wei-guo,et al.The optimal program of 99Tcm labeled radionuclide imaging in diagnosing coronary disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):42.[doi:10.3760/cma.j.issn.1673-4114.2010.01.011]
[5]何建华,喻文才.89SrCl2与153Sm-乙二胺四亚甲基膦酸治疗骨转移癌的对比研究[J].国际放射医学核医学杂志,2009,33(2):86.[doi:10.3760/cma.j.issn.1673-4114.2009.02.007]
HE Jian-hua,YU Wen-cai.Comparison of treatment with 89SrCl2 and 153Sm-ethylenediaminetetramethylene phosphate in metastatic cancers of bone[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):86.[doi:10.3760/cma.j.issn.1673-4114.2009.02.007]
[6]刘键,张现忠,张仕坚,等.99Tcm标记双膦酸盐骨显像剂的研究进展[J].国际放射医学核医学杂志,2009,33(5):296.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.013]
LIU Jian,ZHA NG Xian-zhong,ZHA NG Shi-jian,et al.The new advanced of 99Tcm-labeled bisphosphonates as bone scintigraphy agent[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):296.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.013]
[7]叶慧,莫逸,谢爱民,等.18F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究[J].国际放射医学核医学杂志,2008,32(3):147.
YE Hui,MO Yi,XIE Ai-min,et al.Comparison study of 18F-fluorodeoxyglucose PET-CT and 99Tc-methylene phospho-nate bone scan in detecting bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):147.
[8]郭睿,晋建华,任媛,等.99mTc-枸橼酸盐显像鉴别骨转移癌与良性退行性骨病变[J].国际放射医学核医学杂志,2008,32(3):162.
GUO Rui,JIN Jian-hua,REN Yuan,et al.Differentiation of malignant and degenerative benign bone disease using 99mTc-citrate scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):162.
[9]王娜,刘生.全身骨显像骨外伪影的原因分析[J].国际放射医学核医学杂志,2008,32(5):301.
WANG Na,LIU Sheng.Analysis of artifact imaging of extraosseous tissues in whole-body bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):301.
[10]徐萍,刘强,李锐.99mTc-明胶的制备和生物学分布研究[J].国际放射医学核医学杂志,2008,32(1):19.